Trial Profile
Clinical Trials Insight: 700055729
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2010
Price :
$35
*
At a glance
- Drugs AM 211 (Primary)
- Indications Allergic rhinitis; Asthma; Chronic obstructive pulmonary disease; Hypersensitivity
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Amira Pharmaceuticals
- 20 Apr 2010 New trial record